Common dosing protocols range from 250 to 500 mcg once or twice daily , administered either subcutaneously or intramuscularly
(192): Ferroptosis inhibitor-1 reduced kidney injury molecule 1 (KIM-1), HIF-1, HO-1, and ROS in db/db mouse kidneys, indicating that ferroptosis drives RF/renal dysfunction via the HIF-1/HO-1 pathway
GI side effects during escalation vs maintenance Both compounds share an important characteristic: most gastrointestinal side effects occur during dose escalation, not during maintenance
Recent studies have identified ferroptosis as a contributing factor to keratinocyte dysfunction and inflammation, highlighting the roles of lipid peroxidation, iron dysregulation, and ROS accumulation (189)
CONSULT YOUR PHYSICIAN IF ANY OF THESE CONDITIONS PERSIST Nausea (usually the most common side effect up to 50% of all patients may experience nausea) One of the best ways to avoid nausea is to stay hydrated